Emergency department visits for adverse events related to dietary supplements

New England Journal of Medicine

Volumn 373, Issue 16, 2015, Pages 1531-1540

  Geller, Andrew I ^a   Shehab, Nadine ^a   Weidle, Nina J ^b   Lovegrove, Maribeth C ^a   Wolpert, Beverly J ^c   Timbo, Babgaleh B ^c   Mozersky, Robert P ^c   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Chenega Government Consulting   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRACE ELEMENT; CALCIUM; IRON; POTASSIUM;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; AIRWAY OBSTRUCTION; ALTERNATIVE MEDICINE; ARTICLE; CHILD; DIET SUPPLEMENTATION; DYSPHAGIA; EMERGENCY WARD; FEMALE; HEART PALPITATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; TACHYCARDIA; THORAX PAIN; UNITED STATES; ADVERSE EFFECTS; EMERGENCY HEALTH SERVICE; HEALTH SURVEY; PHYTOTHERAPY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CALCIUM; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; IRON; MICRONUTRIENTS; MIDDLE AGED; PHYTOTHERAPY; POPULATION SURVEILLANCE; POTASSIUM; UNITED STATES; YOUNG ADULT;

EID: 84944472703     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1504267     Document Type: Article

References (41)

1. Dietary Supplement Health and Education Act of 1994. Public Law 103-417, 108 Stat 4325.
2. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med 2013; 173: 355-61.
3. Report of the Commission on Dietary Supplement Labels. Washington, DC: Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 1997 (http://web .health .gov/ dietsupp/ final .pdf).
4. Dietary supplements: FDA may have opportunities to expand its use of reported health problems to oversee products (GAO-13-244). Washington, DC: Government Accountability Office. March 18, 2013 (http://www .gao .gov/ assets/ 660/ 653113 .pdf ).
5. Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011; 141: 261-6.
6. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report 2009: 1-14.
7. Department of Health and Human Services, Food and Drug Administration. New dietary ingredients in dietary supplements - background for industry. March 3, 2014 (http://www .fda .gov/ Food/ Dietary Supplements/ NewDietaryIngredients NotificationProcess/ ucm109764 .htm).
8. Dietary Supplement and Nonprescription Drug Consumer Protection Act. Public Law 109-462, 120 Stat 4500.
9. Adverse event reporting for dietary supplements: an inadequate safety valve (OEI-01-00-00180). Washington, DC: Department of Health and Human Services, Office of the Inspector General. April 2001 (http://oig .hhs .gov/ oei/ reports/ oei-01-00 -00180 .pdf).
10. The Sentinel Initiative - national strategy for monitoring medical product safety. Washington, DC: Department of Health and Human Services, Food and Drug Administration. May 22, 2008 (http://www .fda .gov/ downloads/ Safety/ FDAsSentinelInitiative/ UCM124701 .pdf).
11. Harel Z, Harel S, Wald R, Mamdani M, Bell CM. The frequency and characteristics of dietary supplement recalls in the United States. JAMA Intern Med 2013; 173: 926-8.
12. Dietary Supplement Labeling Act of 2013, S. 1425, 113th Cong. (2013).
13. Consumers Union. Consumers union endorses dietary supplement labeling act. August 1, 2013 (http://consumersunion .org/ news/ consumers-union-endorses-dietary -supplement-labeling-act).
14. Dietary Supplement Safety Act of 2010, S. 3002, 111th Cong. (2010).
15. Denham BE. Dietary supplements - regulatory issues and implications for public health. JAMA 2011; 306: 428-9.
16. Cohen PA, Maller G, DeSouza R, Neal- Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. JAMA 2014; 312: 1691-3.
17. Cohen PA. Hazards of hindsight - monitoring the safety of nutritional supplements. N Engl J Med 2014; 370: 1277-80.
18. Starr RR. Too little, too late: ineffective regulation of dietary supplements in the United States. Am J Public Health 2015; 105: 478-85.
19. Gardiner P, Sarma DN, Low Dog T, et al. The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2008; 17: 962-70.
20. Timbo BB, Ross MP, McCarthy PV, Lin CT. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc 2006; 106: 1966-74.
21. Department of Health and Human Services, Food and Drug Administration. 2008 Health and Diet Survey: topline frequency report (http://www .fda .gov/ Food/ FoodScienceResearch/ ConsumerBehavior Research/ ucm193895 .htm).
22. Dennehy CE, Tsourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Health Syst Pharm 2005; 62: 1476-82.
23. Haller C, Kearney T, Bent S, Ko R, Benowitz N, Olson K. Dietary supplement adverse events: report of a one-year poison center surveillance project. J Med Toxicol 2008; 4: 84-92.
24. Gardiner P, Adams D, Filippelli AC, et al. A systematic review of the reporting of adverse events associated with medical herb use among children. Glob Adv Health Med 2013; 2: 46-55.
25. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System- Cooperative Adverse Drug Event Surveil-lance Project (NEISS-CADES). Med Care 2007; 45: Suppl 2: S96-S102.
26. Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. July 29, 2010 (http://www .cdc .gov/ od/ science/ integrity/ docs/ cdc-policy-distinguishing -public-health-research-nonresearch .pdf).
27. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858-66.
28. Cohen AL, Jhung MA, Budnitz DS. Stimulant medications and attention deficit- hyperactivity disorder. N Engl J Med 2006; 354: 2294-5.
29. Hensrud DD, Engle DD, Scheitel SM. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin Proc 1999; 74: 443-7.
30. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286: 208-16.
31. Gardiner P, Kemper KJ, Legedza A, Phillips RS. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med 2007; 7: 39.
32. Gardiner P, Sadikova E, Filippelli AC, White LF, Jack BW. Medical reconciliation of dietary supplements: don't ask, don't tell. Patient Educ Couns 2015; 98: 512-7.
33. 16 C.F.R. § 1700.14 Subchapter E - Poison Prevention Packaging Act of 1970 Regulations, Part 1700 - Poison Prevention Packaging
34. 38 FR 21247, Aug. 7, 1973, as amended at 41 FR 22266, June 2, 1976
35. 48 FR 57480, December 30, 1983.
36. Budnitz DS, Salis S. Preventing medication overdoses in young children: an opportunity for harm elimination. Pediatrics 2011; 127(6): e1597-e1599.
37. Size, shape, and other physical attributes of generic tablets and capsules: guidance for industry. Silver Spring, MD: Food and Drug Administration Center for Drug Evaluation and Research. June 18, 2015 (http://www .fda .gov/ downloads/ Drugs/ GuidanceComplianceRegulatory Information/ Guidances/ UCM377938 .pdf).
38. Puritan's Pride. Multivitamins (http:// www .puritan .com/ multivitamins-067?cm -re=LeftNav---Link---Multivitamins).
39. Kaye AD, Clarke RC, Sabar R, et al. Herbal medicines: current trends in anesthesiology practice - a hospital survey. J Clin Anesth 2000; 12: 468-71.
40. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. 2011-2012 National Health and Nutrition Examination Survey (NHANES): dietary supplements and prescription medication. May 1, 2012 (http://www .cdc .gov/ nchs/ data/ nhanes/ nhanes-11-12/ dsq .pdf).
41. Iovate Health Sciences International. Hydroxycut weight loss products (http:// www .hydroxycut .com/ products).